Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: Role of the AKT signaling pathway

Oncogene

Volumn 33, Issue 15, 2014, Pages 1986-1996

  Zhu, X ^a,b   Guo, Y ^a   Yao, S ^c   Yan, Q ^a   Xue, M ^a   Hao, T ^a   Zhou, F ^a   Zhu, J ^d   Qin, D ^a   Lu, C ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Quzhou College of Technology   (China)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

angiogenesis; KSHV vIL 6; signal pathway; tumorigenesis

Indexed keywords

ANIMALS; BLOTTING, WESTERN; CARCINOGENESIS; CELL LINE; HERPESVIRUS 8, HUMAN; HUMANS; INTERLEUKIN-6; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; SARCOMA, KAPOSI; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 84899424160     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.136     Document Type: Article

References (62)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-Associated Kaposi's sarcoma. Science 1994; 266: 1865-1869
2. Blum L, Pellet C, Agbalika F, Blanchard G, Morel P, Calvo F, et al. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy. CAIDS 1997; 11: 1653-1655
3. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcomaassociated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-1191
4. Boshoff C, Weiss RA. Epidemiology and pathogenesis of Kaposi's sarcomaassociated herpesvirus. Philos Trans R Soc Lond B Biol Sci. 2001; 356: 517-534
5. Strathdee SA, Veugelers PJ, Moore PS. The epidemiology of HIV-Associated Kaposi's sarcoma: The unraveling mystery. AIDS 1996; 10(Suppl A): S51-S57
6. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 2006; 1: 273-296
7. Mocroft A, Youle M, Phillips AN, Halai R, Easterbrook P, Johnson MA, et al. The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Arch Intern Med 1998; 158: 491-497
8. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993; 67: 277-287
9. Ensoli B, Cafaro A. HIV-1 and Kaposi's sarcoma. Eur J Cancer Prev 1996; 5: 410-412
10. Harrington Jr. W, Sieczkowski L, Sosa C, Chan-A-Sue S, Cai JP, Cabral L, et al. Activation of HHV-8 by HIV-1 tat. Lancet 1997; 349: 774-775
11. Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, Qin D, et al. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-Associated herpesvirus: Role of JAK/STAT signaling. J Virol 2007; 81: 2401-2417
12. Guo HG, Pati S, Sadowska M, Charurat M, Reitz M. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J Virol 2004; 78: 9336-9342
13. Chen X, Cheng L, Jia X, Zeng Y, Yao S, Lv Z, et al. Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-Associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice. Neoplasia 2009; 11: 1272-1284
14. Kestler 3rd HW, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991; 65: 651-662
15. Raymond AD, Campbell-Sims TC, Khan M, Lang M, Huang MB, Bond VC, et al. HIV Type 1 Nef is released from infected cells in CD45() microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retroviruse 2011; 27: 167-178
16. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol 2005; 17: 879-887
17. Guy B, Kieny MP, Riviere Y, Le Peuch C, Dott K, Girard M, et al. HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 1987; 330: 266-269
18. Fujii Y, Otake K, Tashiro M, Adachi A. Soluble Nef antigen of HIV-1 is cytotoxic for human CD4 T cells. FEBS Lett 1996; 393: 93-96
19. Guy B, Riviere Y, Dott K, Regnault A, Kieny MP. Mutational analysis of the HIV nef protein. Virology 1990; 176: 413-425
20. Macreadie IG, Fernley R, Castelli LA, Lucantoni A, White J, Azad A. Expression of HIV-1 nef in yeast causes membrane perturbation and release of the myristylated Nef protein. J Biomed Sci 1998; 5: 203-210
21. Cullen BR. HIV-1 auxiliary proteins: Making connections in a dying cell. Cell 1998; 93: 685-692
22. Qiao X, He B, Chiu A, Knowles DM, Chadburn A, Cerutti A. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat Immunol 2006; 7: 302-310
23. Xu W, Santini PA, Sullivan JS, He B, Shan M, Ball SC, et al. HIV-1 evades virusspecific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol 2009; 10: 1008-1017
24. He JC, Husain M, Sunamoto M, D'Agati VD, Klotman ME, Iyengar R, et al. Nef stimulates proliferation of glomerular podocytes through activation of Srcdependent Stat3 and MAPK1,2 pathways. J Clin Invest 2004; 114: 643-651
25. Husain M, D'Agati VD, He JC, Klotman ME, Klotman PE. HIV-1 Nef induces dedifferentiation of podocytes in vivo: A characteristic feature of HIVAN. AIDS 2005; 19: 1975-1980
26. Choi J, Walker J, Boichuk S, Kirkiles-Smith N, Torpey N, Pober JS, et al. Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4 T cells in a Nef-dependent manner in vitro and in vivo. J Virol 2005; 79: 264-276
27. Choi J, Walker J, Talbert-Slagle K, Wright P, Pober JS, Alexander L. Endothelial cells promote human immunodeficiency virus replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT. J Virol 2005; 79: 11194-11204
28. Marecki JC, Cool CD, Parr JE, Beckey VE, Luciw PA, Tarantal AF, et al. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med 2006; 174: 437-445
29. Molden J, Chang Y, You Y, Moore PS, Goldsmith MAA. Kaposi's sarcomaassociated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 1997; 272: 19625-19631
30. Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-Associated herpesvirus-encoded interleukin-6. Blood 1999; 93: 4034-4043
31. Aoki Y, Jones KD, Tosato G. Kaposi's sarcoma-Associated herpesvirus-encoded interleukin-6. J Hematother Stem Cell Res 2000; 9: 137-145
32. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994; 76: 853-864
33. Peter F. HIV nef: The mother of all evil? Immunity 1998; 9: 433-437
34. Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G. HIV-1 Nef downregulates MHC-I by a PACS-1-And PI3K-regulated ARF6 endocytic pathway. Cell 2002; 111: 853-866
35. Greenway AL, Holloway G, McPhee DA, Ellis P, Cornall A, Lidman M. HIV-1 Nef control of cell signalling molecules: Multiple strategies to promote virus replication. J Biosci 2003; 28: 323-335
36. Mullberg J, Geib T, Jostock T, Hoischen SH, Vollmer P, Voltz N, et al. IL-6 receptor independent stimulation of human gp130 by viral IL-6. J Immunol 2000; 164: 4672-4677
37. Meads MB, Medveczky PG. Kaposi's sarcoma-Associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: Evidence for a unique autocrine signaling mechanism. J Biol Chem 2004; 279: 51793-51803
38. Kaaya EE, Parravicini C, Ordonez C, Gendelman R, Berti E, Gallo RC, et al. Heterogeneity of spindle cells in Kaposi's sarcoma: Comparison of cells in lesions and in culture. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 295-305
39. Cerimele F, Curreli F, Ely S, Friedman-Kien AE, Cesarman E, Flore O. Kaposi's sarcoma-Associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J Virol 2001; 75: 2435-2443
40. Akula SM, Naranatt PP, Walia NS, Wang FZ, Fegley B, Chandran B. Kaposi's sarcoma-Associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J Virol 2003; 77: 7978-7990
41. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 1998; 95: 163-175
42. Delli Bovi P, Donti E, Knowles 2nd DM, Friedman-Kien A, Luciw PA, Dina D, et al. Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-Associated Kaposi's sarcoma. Cancer Res 1986; 46: 6333-6338
43. Zhu X, Zhou F, Qin D, Zeng Y, Lv Z, Yao S, et al. Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-Associated herpesvirus: Role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-kappaB signaling pathways. J Mol Biol 2011; 410: 1035-1051
44. Mercader M, Taddeo B, Panella JR, Chandran B, Nickoloff BJ, Foreman KE. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol 2000; 156: 1961-1971
45. Merat R, Amara A, Lebbe C, De The H, Morel P, Saib A. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-Associated herpesvirus (KSHV) reactivation. Int J Cancer 2002; 97: 791-795
46. Varthakavi V, Browning PJ, Spearman P. Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-Associated herpesvirus. J Virol 1999; 73: 10329-10338
47. Voelkel NF, Cool CD, Flores S. From viral infection to pulmonary arterial hypertension: A role for viral proteins? AIDS 2008; 22(Suppl 3): S49-S53
48. Morris VA, Punjabi AS, Lagunoff M. Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-Associated herpesvirus-induced lymphatic reprogramming of endothelial cells. J Virol 2008; 82: 8771-8779
49. Morris VA, Punjabi AS, Wells RC, Wittkopp CJ, Vart R, Lagunoff M. The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. Virology 2012; 428: 112-120
50. Suthaus J, Adam N, Grotzinger J, Scheller J, Rose-John S. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization. Eur J Cell Biol 2011; 90: 495-504
51. Wan X, Wang H, Nicholas J. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J Virol 1999; 73: 8268-8278
52. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739-1744
53. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection? Lancet 1990; 335: 123-128
54. Leonard JA, Filzen T, Carter CC, Schaefer M, Collins KL. HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements. J Virol 2011; 85: 6867-6881
55. Linnemann T, Zheng YH, Mandic R, Peterlin BM. Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-Activated kinase and increased production of HIV. Virology 2002; 294: 246-255
56. Wolf D, Witte V, Laffert B, Blume K, Stromer E, Trapp S, et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-Apoptotic signals. Nat Med 2001; 7: 1217-1224
57. Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, Hamm LL, et al. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 2011; 71: 6061-6072
58. Junkin M, Wong PK. Probing cell migration in confined environments by plasma lithography. Biomaterials 2011; 32: 1848-1855
59. Qin D, Feng N, Fan W, Ma X, Yan Q, Lv Z, et al. Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-Associated herpesvirus by herpes simplex virus type 1. BMC Microbiol 2011; 11: 240
60. Zhou F, Xue M, Qin D, Zhu X, Wang C, Zhu J, et al. HIV-1 Tat Promotes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3beta signaling pathway. PloS One 2013; 8: E53145
61. Qin D, Zeng Y, Qian C, Huang Z, Lv Z, Cheng L, et al. Induction of lytic cycle replication of Kaposi's sarcoma-Associated herpesvirus by herpes simplex virus type 1: Involvement of IL-10 and IL-4. Cell Microbiol 2008; 10: 713-728
62. Tang Q, Qin D, Lv Z, Zhu X, Ma X, Yan Q, et al. Herpes simplex virus type 2 Triggers reactivation of Kaposi's sarcoma-Associated herpesvirus from latency and collaborates with HIV-1 Tat. PLoS One 2012; 7: E31652